First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL).
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Paraganglioma; Pheochromocytoma
- Focus Biomarker; Therapeutic Use
- Acronyms FIRSTMAPPP
- 25 Jan 2017 Planned End Date changed from 1 Dec 2019 to 1 Jun 2021.
- 25 Jan 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Jun 2021.
- 06 Apr 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2010-024621-20).